Clinical Trials Browser

Phase 3 × Peripheral Blood Stem Cell Transplantation × 30 days × Clear all

NCT00114101 2026-05-29

Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant

Phase 3 Active not recruiting

460 enrolled 11 charts

Smoldering Multiple Myeloma, Multiple Myeloma